Extended Data Table 2 ∣.
Rates of death within 28 days of a positive test among study participants
| Death rates | SGTF prevalence (%) |
Missingness (%) | ||||
|---|---|---|---|---|---|---|
| All | Missing | SGTF | Non-SGTF | |||
| 17,452 / 57,616,200 (3.03) | 12,507 / 27,937,559 (4.48) | 3,088 / 16,617,517 (1.86) | 1,857 / 13,061,124 (1.42) | 62% | 72% | |
| Sex | ||||||
| Female | 9,244 / 30,944,020 (2.99) | 7,053 / 15,398,004 (4.58) | 1,361 / 8,619,534 (1.58) | 830 / 6,926,482 (1.2) | 62% | 76% |
| Male | 8,208 / 26,672,181 (3.08) | 5,454 / 12,539,554 (4.35) | 1,727 / 7,997,984 (2.16) | 1,027 / 6,134,643 (1.67) | 63% | 66% |
| Age | ||||||
| 1-34 | 71 / 25,680,074 (0.03) | 29 / 12,326,846 (0.02) | 25 / 7,508,250 (0.03) | 17 / 5,844,978 (0.03) | 60% | 41% |
| 35-54 | 712 / 19,864,316 (0.36) | 341 / 9,403,924 (0.36) | 261 / 5,943,218 (0.44) | 110 / 4,517,174(0.24) | 70% | 48% |
| 55-69 | 2,244 / 8,701,146 (2.58) | 1,117 / 4,165,412 (2.68) | 787 / 2,495,452 (3.15) | 340 / 2,040,282 (1.67) | 70% | 50% |
| 70-84 | 5,839 / 2,417,392 (24.15) | 3,939 / 1,300,303 (30.29) | 1,144 / 563,478 (20.3) | 756 / 553,610 (13.66) | 60% | 67% |
| 85 and older | 8,586 / 953,274 (90.07) | 7,081 / 741,074 (95.55) | 871 / 107,120 (81.31) | 634 / 105,080 (60.33) | 58% | 82% |
| Place of residence | ||||||
| Residential | 6,790 / 54,144,918 (1.25) | 3,114 / 25,493,353 (1.22) | 2,363 / 16,050,245 (1.47) | 1,313 / 12,601,320 (1.04) | 64% | 46% |
| Care/Nursing home | 10,343 / 1,633,711 (63.31) | 9,152 / 1,448,972 (63.16) | 671 / 88,819 (75.55) | 520 / 95,920 (54.21) | 56% | 88% |
| Other/Unknown | 319 / 1,837,572 (1.74) | 241 / 995,234 (2.42) | 54 / 478,453 (1.13) | 24 / 363,885 (0.66) | 69% | 76% |
| Ethnicity | ||||||
| White | 15,403 / 42,509,581 (3.62) | 11,306 / 20,333,667 (5.56) | 2,510 / 12,178,060 (2.06) | 1,587 / 9,997,854 (1.59) | 61% | 73% |
| Asian | 1,234 / 7,881,667 (1.57) | 648 / 3,621,568 (1.79) | 388 / 2,346,561 (1.65) | 198 / 1,913,538 (1.03) | 66% | 53% |
| Black | 334 / 2,704,512 (1.23) | 205 / 1,532,482 (1.34) | 101 / 796,623 (1.27) | 28 / 375,406 (0.75) | 78% | 61% |
| Other/Mixed/Unknown | 481 / 4,520,440 (1.06) | 348 / 2,449,842 (1.42) | 89 / 1,296,272 (0.69) | 44 / 774,326 (0.57) | 67% | 72% |
| IMD decile | ||||||
| 1-2 (most deprived) | 3,407 / 12,934,018 (2.63) | 1,972 / 5,512,666 (3.58) | 816 / 3,711,599 (2.2) | 619 / 3,709,752 (1.67) | 57% | 58% |
| 3-4 | 3,656 / 13,332,300 (2.74) | 2,541 / 6,699,684 (3.79) | 726 / 3,821,830 (1.9) | 389 / 2,810,787 (1.38) | 65% | 70% |
| 5-6 | 3,642 / 11,555,099 (3.15) | 2,801 / 5,923,094 (4.73) | 549 / 3,307,366 (1.66) | 292 / 2,324,639 (1.26) | 65% | 77% |
| 7-8 | 3,475 / 10,477,056 (3.32) | 2,671 / 5,208,213 (5.13) | 522 / 2,997,440 (1.74) | 282 / 2,271,402 (1.24) | 65% | 77% |
| 9-10 | 3,272 / 9,317,728 (3.51) | 2,522 / 4,593,902 (5.49) | 475 / 2,779,282 (1.71) | 275 / 1,944,544 (1.41) | 63% | 77% |
| NHS England region | ||||||
| East of England | 2,513 / 7,214,404 (3.48) | 2,163 / 4,623,842 (4.68) | 272 / 1,976,732 (1.38) | 78 / 613,831 (1.27) | 78% | 86% |
| London | 1,875 / 13,363,072 (1.4) | 1,439 / 7,990,202 (1.8) | 359 / 3,999,013 (0.9) | 77 / 1,373,858 (0.56) | 82% | 77% |
| Midlands | 3,596 / 10,680,665 (3.37) | 2,448 / 4,839,783 (5.06) | 678 / 2,683,772 (2.53) | 470 / 3,157,110 (1.49) | 59% | 68% |
| North East and Yorkshire | 2,175 / 6,979,508 (3.12) | 944 / 1,528,482 (6.18) | 565 / 1,922,484 (2.94) | 666 / 3,528,543 (1.89) | 46% | 43% |
| North West | 1,869 / 6,745,667 (2.77) | 910 / 1,439,165 (6.32) | 554 / 2,393,090 (2.31) | 405 / 2,913,412 (1.39) | 58% | 49% |
| South East | 3,731 / 9,274,042 (4.02) | 3,155 / 5,136,804 (6.14) | 496 / 3,148,042 (1.58) | 80 / 989,196 (0.81) | 86% | 85% |
| South West | 1,693 / 3,358,841 (5.04) | 1,448 / 2,379,282 (6.09) | 164 / 494,384 (3.32) | 81 / 485,175 (1.67) | 67% | 86% |
| Specimen date | ||||||
| 1 Nov-21 Nov | 2,143 / 9,726,040 (2.2) | 1,405 / 3,317,578 (4.24) | 29 / 371,689 (0.78) | 709 / 6,036,774 (1.17) | 4% | 66% |
| 22 Nov-12 Dec | 1,994 / 6,631,448 (3.01) | 1,452 / 2,409,916 (6.03) | 141 / 1,254,200 (1.12) | 401 / 2,967,330 (1.35) | 26% | 73% |
| 13 Dec-2 Jan | 4,250 / 18,432,794 (2.31) | 3,112 / 9,900,846 (3.14) | 777 / 5,993,916 (1.3) | 361 / 2,538,032 (1.42) | 68% | 73% |
| 3 Jan-23 Jan | 7,621 / 19,281,830 (3.95) | 5,641 / 10,464,988 (5.39) | 1,638 / 7,409,298 (2.21) | 342 / 1,407,543 (2.43) | 83% | 74% |
| 24 Jan-14 Feb | 1,444 / 3,544,088 (4.07) | 897 / 1,844,230 (4.86) | 503 / 1,588,412 (3.17) | 44 / 111,445 (3.95) | 92% | 62% |
Total number of deaths, number of days of follow-up and deaths per 10,000 days of follow-up are reported for: all deaths, deaths with Missing SGTF status, deaths with known SGTF and deaths with known Non-SGTF. SGTF prevalence among deaths with non-missing SGTF status (%) and missingness in SGTF status among deaths are also reported.